ABSTRACT Assessment of the effects of pharmacologic agents on renal blood flow (RBF) is clinically important in many disease states, including hypertension and congestive heart failure.
Drugs were always infused in the above-mentioned order.
Echo contrast agent preparation. The microbubble solutions used as echo contrast agents were prepared in a standardized manner.9' 10 A 10 ml syringe was filled with 8 ml of sterile Renografin-76 and placed 1/2 inch into the horn portion of the sonicator unit (Model 220 Heat Systems/Ultrasonics of Plainview, NY). With the energy settings at 50% duty (180 W/cm), the Renografin-76 was sonicated for 30 sec. Immediately after the energy was turned off, the plunger was reinserted into the syringe and the microcavitated solution was injected into the multipurpose catheter. Assessment of the size of the microbubbles was performed in a manner previously described.9' 10 The average diameter obtained was 4.4 + 2.8 ,um by laser analysis. 7 Figure 1 demonstrates serial recordings of a single bolus injection of Renografin-76 given before any drug infusions.
Baseline conditions are represented in frame 1. After the bolus injection, the contrast material is seen in the interlobar arteries (frames 2 and 3) before reaching the renal cortex (frame 4). The last two frames represent echocontrast washout (frames 5 and 6).
Data analysis. Each dog served as its own control. The paired t test was used to compare data. A p value < .05 was considered statistically significant. The contrast renal ultrasound images were digitized with an off-line computer (Quantic 1200, Bruce Franklin, Inc. Bellevue, WA). An edge-detection algorithm permitted rapid, accurate detection of the renal cortical borders throughout the injection cycle. 4 The outer cortex of the kidney was then divided radially into 32 equal regions. Each of these individual regions was analyzed by a videodensitometric technique in which mean pixel intensity was plotted against time. A typical example of an intensity (gray-level) curve obtained during an injection of Renografin-76 microbubbles is shown in figure 2 , A. Initially a relatively flat baseline gray intensity is noted, followed by a rapid rise corresponding to the opacification of the renal cortex induced by the bolus injection of Renografin-76. This is followed by a decay slope and return to near baseline intensity. A semilog plot of intensity (gray level) vs time (seconds) for these data is shown in figure 2 , B. After the peak, the logarithm of intensity (gray level) decreases linearly with time (r = -.96). This suggests that the best fit for the decay slope portion of each curve is represented by a monoexponential function. Therefore a monoexponential function was used to describe the decay slope portion of each curve.
From these data, individual decay rates (tl/2) were calculated. A linear least-square fit of the natural logarithm of the intensity minus the preinfusion background was used, with tl/2 being proportional to the negative reciprocal of the slope of least fit. The t'/2 values (seconds) were then used as measures of renal perfusion for the remainder of the analysis.
Results
Hemodynamics. Control data acquired before infusions of bradykinin and norepinephrine were similar for heart rate as well as aortic systolic and diastolic pressures. Intrarenal infusions of bradykinin and norepinephrine as well as intra-aortic injections of sonicated Renografin-76 did not alter these variables (table 1) . Renal explain the fact that the decay portion only returned to near-baseline inten mained unchanged during the intra-aort sonicated Renografin-76. 
